Hours

Minutes

Seconds

-40%

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Companyâ€™s customer base includes mainly ambulance services and emergency departments.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

25/08 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
18/06/26	1.835 kr	+0.55%	25
17/06/26	1.825 kr	-3.18%	13,116
16/06/26	1.885 kr	+4.72%	15,098
15/06/26	1.800 kr	0.00%	260
12/06/26	1.800 kr	0.00%	225

Delayed Quote Nasdaq Stockholm

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm Other stock markets 02:00:00 19/06/26 am AEST			5-day change	1st Jan Change
1.835 ^SEK	+0.55%		+1.94%	+51.03%

07/05	Ortivus AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04/05	Ortivus Exits H&E Solutions Shareholding	MT

Market Cap	163M 17.02M 14.84M 13.75M 12.87M 24.13M 1.61B 24.28M 63.2M 791M 63.9M 62.53M 2.75B	P/E 2024	-2.47x	P/E 2025	-2.86x
Enterprise Value	174M 18.13M 15.81M 14.64M 13.71M 25.71M 1.71B 25.86M 67.33M 842M 68.07M 66.61M 2.92B	EV / Sales 2024	1.19x	EV / Sales 2025	1.61x
Free-Float	83.17%	Yield 2024 *	-	Yield 2025	-

07/05	Ortivus AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04/05	Ortivus Exits H&E Solutions Shareholding	MT
04/05	Ortivus completes sale of its holding in H&E Solutions	RE
22/04	Ortivus AB Appoints Matti Zemack as New Chief Product Officer	CI
20/02	Ortivus AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
04/02	19 Stocks Reach New 52-Week Highs on the Stockholm Stock Exchange So Far Today	FW
14/01	Ponderus Invest has announced final outcome of cash offer to shareholders of Ortivus	RE
12/01	Ponderus Invest AB completed the acquisition of remaining 39.42% stake in Ortivus AB (OM:ORTI B).	CI
22/12	Ponderus announces approval regarding cash offer to shareholders of Ortivus	RE
19/12	Ortivus: Independent bid committee unanimously recommends to not accept mandatory cash offer	RE
17/12	Ortivus: Appointment of Minni Raij as CFO	RE
17/12	Ortivus AB Appoints Minni Raij As Chief Financial Officer, Effective February 16, 2026	CI
03/12	Ponderus Invest AB proposed to acquire remaining 39.42% stake in Ortivus AB (OM:ORTI B) for approximately SEK 42.6 million.	CI

28/05	PRESS RELEASE	AQ
07/05	Interim Report for Ortivus AB (publ) for the period January-March 2026	AQ
04/05	Ortivus AB completes sale of its holding in H&E Solutions AB and realises a profit	AQ
22/04	Ortivus AB welcomes Matti Zemack as new Chief Product Officer	AQ
31/03	Ortivus AB publishes the Annual Report of 2025	AQ

Ortivus AB Stock

Stocks

ORTI B

SE0000123085

Advanced Medical Equipment & Technology

Valuation: Ortivus AB

Chart: Ortivus AB

Latest news : Ortivus AB

Press Releases: Ortivus AB

Quotes and Performance

Course Extremes

Managers and Directors: Ortivus AB

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	+0.55%
1 week	+1.94%
Current month	+1.94%
1 month	+1.38%
3 months	+25.68%
6 months	+51.03%
Current year	+51.03%

1 week	1.65	1.99
1 month	1.54	2
Current year	1.14	2.14
1 year	0.8	2.14
3 years	0.8	4.99
5 years	0.8	7.74
10 years	0.8	8.9

Manager	Title	Age	Since
Gustaf Nordenhök CEO	Chief Executive Officer	-	01/01/2024
Minni Raij DFI	Director of Finance/CFO	-	16/02/2026
Gabriel Åhbeck CTO	Chief Tech/Sci/R&D Officer	55	01/01/2013

Director	Title	Age	Since
Peter Edwall BRD	Director/Board Member	71	01/01/2008
Anna Klevby Dalgaard BRD	Director/Board Member	47	01/01/2017
Jarnberg Ulf BRD	Director/Board Member	62	01/01/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORTIVUS AB	+0.55%	+1.94%	+37.97%	-56.52%	17.07M
THERMO FISHER SCIENTIFIC, INC.	-1.22%	-2.32%	+18.35%	-13.53%	173B
INTUITIVE SURGICAL, INC.	+15.64%	-1.48%	-20.16%	+23.51%	144B
DANAHER CORPORATION	-1.87%	-2.00%	-8.88%	-26.73%	125B
BOSTON SCIENTIFIC CORPORATION	+1.71%	-3.99%	-55.32%	-16.62%	67.32B
EDWARDS LIFESCIENCES CORPORATION	-0.10%	+1.87%	+18.09%	-4.98%	50.3B
SIEMENS HEALTHINEERS AG	-0.58%	-1.16%	-25.42%	-34.65%	44.09B
AGILENT TECHNOLOGIES, INC.	+2.20%	-1.92%	+9.99%	+4.90%	35.89B
WATERS CORPORATION	-0.44%	-1.20%	+4.74%	+32.04%	34.9B
GE HEALTHCARE TECHNOLOGIES INC.	+9.82%	-4.53%	-14.33%	-21.69%	28.02B
Average	+0.53%	-1.72%	-3.50%	-11.43%	70.26B
Weighted average by Cap.	+0.53%	-2.00%	-6.63%	-6.42%

	2024	2025
Net sales	80.41M 8.39M 7.32M 6.78M 6.35M 11.9M 792M 11.97M 31.16M 390M 31.51M 30.83M 1.35B	73.4M 7.66M 6.68M 6.19M 5.79M 10.86M 723M 10.93M 28.45M 356M 28.76M 28.14M 1.24B
Net income	-24.9M -2.6M -2.27M -2.1M -1.97M -3.69M -245M -3.71M -9.65M -121M -9.76M -9.55M -419M	-21.88M -2.28M -1.99M -1.84M -1.73M -3.24M -215M -3.26M -8.48M -106M -8.57M -8.39M -368M
Net Debt	30.75M 3.21M 2.8M 2.59M 2.43M 4.55M 303M 4.58M 11.92M 149M 12.05M 11.79M 518M	10.64M 1.11M 968K 897K 840K 1.57M 105M 1.58M 4.12M 51.58M 4.17M 4.08M 179M